+

WO1995011659A3 - Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation - Google Patents

Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation Download PDF

Info

Publication number
WO1995011659A3
WO1995011659A3 PCT/UA1994/000025 UA9400025W WO9511659A3 WO 1995011659 A3 WO1995011659 A3 WO 1995011659A3 UA 9400025 W UA9400025 W UA 9400025W WO 9511659 A3 WO9511659 A3 WO 9511659A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceutical preparation
cell suspension
immuno
treating sugar
Prior art date
Application number
PCT/UA1994/000025
Other languages
French (fr)
Russian (ru)
Other versions
WO1995011659A2 (en
Inventor
Andrei Semenovich Efimov
Alexandr Ivanovich Smikodub
Kaya Alla Vladimirovna Novits
Original Assignee
Ts Embrionalnych Tkanei Emcell
Andrei Semenovich Efimov
Alexandr Ivanovich Smikodub
Kaya Alla Vladimirovna Novits
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ts Embrionalnych Tkanei Emcell, Andrei Semenovich Efimov, Alexandr Ivanovich Smikodub, Kaya Alla Vladimirovna Novits filed Critical Ts Embrionalnych Tkanei Emcell
Priority to NL9420012A priority Critical patent/NL194693C/en
Publication of WO1995011659A2 publication Critical patent/WO1995011659A2/en
Publication of WO1995011659A3 publication Critical patent/WO1995011659A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to medicine, in particular cell therapy. A patent is sought for a pharmaceutical preparation characterized by a specific composition and quantitative indicators of a cell suspension obtained from native or cryogenically preserved haemopoietic tissue from a human embryo liver and/or spleen. In addition, a patent is sought for a method of treating sugar diabetes involving the introduction of the said pharmaceutical preparation, which is selected in the light of the patient's individual indicators from a specially created tissue bank containing a variety of samples, the same sample being used for a subsequent application.
PCT/UA1994/000025 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation WO1995011659A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL9420012A NL194693C (en) 1993-10-18 1994-10-17 Method for the preparation of medicinal preparations for treating diabetes.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA94020324 1993-10-18
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation

Publications (2)

Publication Number Publication Date
WO1995011659A2 WO1995011659A2 (en) 1995-05-04
WO1995011659A3 true WO1995011659A3 (en) 1995-06-01

Family

ID=21688946

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/UA1994/000025 WO1995011659A2 (en) 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation

Country Status (5)

Country Link
CA (1) CA2152078A1 (en)
NL (1) NL194693C (en)
RU (1) RU2126260C1 (en)
UA (1) UA27048C2 (en)
WO (1) WO1995011659A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035464A1 (en) * 1998-12-16 2000-06-22 Tsentr Embrionalnykh Tkanei 'emcell' Method for treating patients using cellular suspensions of embryonic tissues
RU2226104C2 (en) * 1998-12-16 2004-03-27 Центр эмбриональных тканей "ЭМСЕЛЛ" Method for treating patients with embryonic cellular suspensions
RU2160112C1 (en) * 2000-04-10 2000-12-10 Сухих Геннадий Тихонович Method for producing cellular transplant from fetus tissues
RU2219894C2 (en) * 2001-01-03 2003-12-27 Лобова Любовь Иннокентьевна Method of treating diabetes mellitus in children and adolescences
RU2191388C1 (en) * 2001-12-18 2002-10-20 Закрытое акционерное общество "РЕМЕТЭКС" Truncal nerve cells, cells culture and biotransplant for allotransplanting and method for preparing the biotransplant
RU2261049C2 (en) * 2003-03-18 2005-09-27 Государственное учреждение системы высшего и послевузовского профессионального образования "Сибирский государственный медицинский университет" Method for treating patients for diabetic low extremity gangrene
RU2280462C2 (en) * 2004-04-09 2006-07-27 Александр Сергеевич Тепляшин Method for detaching mesenchyma trunk cells
RU2265443C1 (en) * 2004-05-14 2005-12-10 ЗАО "РеМеТэкс" Biotransplant and method for treating the cases of diabetes mellitus of type i and ii
RU2301069C2 (en) * 2004-06-10 2007-06-20 Муниципальное учреждение здравоохранения "Городская клиническая больница №3" Method for treating complicated varicose and post-thrombophlebitic disease cases
RU2250773C1 (en) * 2004-07-16 2005-04-27 Центральный научно-исследовательский рентгено-радиологический институт МЗ РФ (ЦНИРРИ) Method for treating the cases of allergic diseases
RU2290808C2 (en) * 2004-12-06 2007-01-10 Институт физиологии Коми научного центра Уральского отделения Российской Академии Наук Cryoprotective solution for leukocyte freezing at low temperature
RU2007112288A (en) * 2007-04-03 2008-10-10 Александр Сергеевич Ботин (RU) COMPOSITION FOR STIMULATING GROWTH AND REGENERATION OF CELLS, AND ALSO WAY OF ITS PRODUCTION
RU2441284C2 (en) * 2008-03-25 2012-01-27 Оксана Валентиновна Вежан Method for improving physical endurance in experiment

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
GB1592637A (en) * 1978-03-22 1981-07-08 Parmer L P Lipid extract for inhibiting platelet function in blood
SU1158201A1 (en) * 1983-06-03 1985-05-30 Ленинградское Ордена Ленина,Ордена Трудового Красного Знамени Производственное Объединение Мясной Промышленности Им.С.М.Кирова Method of obtaining stimulator from mammalia spleen
SU1367837A3 (en) * 1980-01-15 1988-01-15 Рихтер Гедеон Ведьесети Дьяр Рт (Инопредприятие) Method of producing agent selectively inhibiting growth or reproduction of normal and leukemia cells of myeloids
EP0357958A2 (en) * 1988-08-04 1990-03-14 Schwarz Pharma Ag Pharmaceutical preparation against viral diseases comprising a liver extract
WO1992010197A1 (en) * 1990-12-11 1992-06-25 Zetesis S.P.A. Substances of polypeptide nature useful in human therapy

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592637A (en) * 1978-03-22 1981-07-08 Parmer L P Lipid extract for inhibiting platelet function in blood
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
SU1367837A3 (en) * 1980-01-15 1988-01-15 Рихтер Гедеон Ведьесети Дьяр Рт (Инопредприятие) Method of producing agent selectively inhibiting growth or reproduction of normal and leukemia cells of myeloids
SU1158201A1 (en) * 1983-06-03 1985-05-30 Ленинградское Ордена Ленина,Ордена Трудового Красного Знамени Производственное Объединение Мясной Промышленности Им.С.М.Кирова Method of obtaining stimulator from mammalia spleen
EP0357958A2 (en) * 1988-08-04 1990-03-14 Schwarz Pharma Ag Pharmaceutical preparation against viral diseases comprising a liver extract
WO1992010197A1 (en) * 1990-12-11 1992-06-25 Zetesis S.P.A. Substances of polypeptide nature useful in human therapy

Also Published As

Publication number Publication date
NL194693C (en) 2002-12-03
NL9420012A (en) 1995-12-01
NL194693B (en) 2002-08-01
UA27048C2 (en) 2000-02-28
WO1995011659A2 (en) 1995-05-04
RU2126260C1 (en) 1999-02-20
CA2152078A1 (en) 1995-05-27

Similar Documents

Publication Publication Date Title
Ghalayini et al. Phosphatidylinositol 4, 5-bisphosphate: light-mediated breakdown in the vertebrate retina
WO1995011659A3 (en) Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation
DE69839326T2 (en) COMPOSITIONS AND METHODS FOR MODULATING THE CELLULAR ACTIVITY OF NF-kappaB
EP0021152B1 (en) Process for the immunological determination of basement membrane material, specific basement membrane fragments therefor and process for preparing or winning them
EP1870466A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
ZA958444B (en) Biological active proteins
WO2001000828A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2000060076A3 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
WO2000060077A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
ATE17858T1 (en) ANGIOTROPINS FROM WLEUCCYTES AND INFLAMMATED TISSUES: A NEW CLASS OF NATURAL CHEMOTROPIC AND MITOGENIC PROTEINS FOR THE SPECIFIC INDUCTION OF REGULATED GROWTH OF BLOOD VESSELS, FOR NEW ANGELIZATION OF TISSUES AND FOR THE MORPHOGENESIS OF BLOOD VESSEL BRANCHING; PROCESSES FOR THEIR BIOTECHNICAL PRODUCTION AND PHARMACEUTICAL COMPOSITIONS.
NO953781L (en) Therapeutic application of keratinocyte growth factor
EP1715043A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
Sakamoto et al. Collagenase and bone resorption: isolation of collagenase from culture medium containing serum after stimulation of bone resorption by addition of parathyroid hormone extract
Murphy et al. Erythrocyte microtubule assembly in vitro. Determination of the effects of erythrocyte tau, tubulin isoforms, and tubulin oligomers on erythrocyte tubulin assembly, and comparison with brain microtubule assembly.
RU95120155A (en) DRUG IMMUNO-CORRECTIVE ACTION ON THE BASIS OF CELL SUSPENSION AND METHOD FOR TREATING DIABETES WITH USE OF THIS DRUG
Tsunekawa et al. Calpain proteolysis of free and bound forms of calponin, a troponin T‐like protein in smooth muscle
DK0588118T3 (en) Carboxypeptidase-like protein attached to bones as well as process for their preparation
RU95120165A (en) DRUG IMMUNE SUBSTITUTING ACTION ON THE BASIS OF CELLULAR SUSPENSION AND METHOD FOR TREATMENT OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV INFECTION) USING THIS ANTID
DK0683791T3 (en) Aqueous protein composition, glycoprotein contained therein, process for obtaining it and uses thereof
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
Shuang-Lin et al. Antithrombin III enhances the motility and chemotaxis of boar sperm
Segal et al. 3, 5, 3′-Tri-iodothyronine enhances sugar transport in rat thymocytes by increasing the intrinsic activity of the plasma membrane sugar transporter
RU95101900A (en) Medicinal preparation for arthritis treatment and a method of its preparing
Kellermann Further studies on the AB0-typing of ancient bones

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA ES NL RU US

AK Designated states

Kind code of ref document: A3

Designated state(s): CA ES NL RU US

ENP Entry into the national phase

Ref document number: 9550021

Country of ref document: ES

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 009550021

Country of ref document: ES

Ref document number: P009550021

Country of ref document: ES

WWE Wipo information: entry into national phase

Ref document number: 2152078

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 1995 481478

Country of ref document: US

Date of ref document: 19950915

Kind code of ref document: A

WWR Wipo information: refused in national office

Ref document number: 9550021

Country of ref document: ES

Kind code of ref document: A

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载